MedMira, Inc. (MIR) | WebDisclosure

Switch to English

8296	Sociétés
114902	Mots-clés
55332	Articles
62460	Communiqués

Accueil
Sociétés
MedMira, Inc.

BRÈVE

publiée le 01/05/2024 à 04:05, il y a 6 mois 20 jours

MedMira Appoints New Vice President of Business Development

Growth Strategy Business Development MedMira Rene Bell US Healthcare Market
COMMUNIQUÉ DE PRESSE

publié le 01/05/2024 à 04:00, il y a 6 mois 20 jours

MedMira Announces the Hire of Vice President of Business Development
MedMira Inc. expands commercialisation team, appoints Rene Bell as Vice President of Business Development. Bell to focus on sales growth and partnerships in the US market

Sales Business Development US Market MedMira Inc. Rene Bell
BRÈVE

publiée le 02/04/2024 à 04:35, il y a 7 mois 19 jours

MedMira Reports on Q2 FY2024 Financial Results and Business Developments

Financial Results Revenue Growth FDA Clearance Health Canada MedMira
BRÈVE

publiée le 02/04/2024 à 04:35, il y a 7 mois 19 jours

MedMira rend compte des résultats financiers et de l'évolution de l'activité du deuxième trimestre de l'exercice 2024

Résultats Financiers Hausse Des Revenus Autorisation De La FDA MedMira Santé Canada
COMMUNIQUÉ DE PRESSE

publié le 02/04/2024 à 04:30, il y a 7 mois 19 jours

MedMira Reports Second Quarter Results FY2024
MedMira Inc. reports Q2 FY2024 financial results & milestones achieved including US FDA 510(k) clearance for Reveal® G4 Rapid HIV-1/2 test

Financial Results MedMira Inc. Q2 FY2024 US FDA 510(k) Reveal® G4 Rapid HIV-1/2
BRÈVE

publiée le 13/03/2024 à 21:35, il y a 8 mois 7 jours

MedMira Receives Canadian Patent for Innovative Diagnostic System

Healthcare Innovation MedMira Canadian Patent Diagnostic System RVF Technology
BRÈVE

publiée le 13/03/2024 à 21:35, il y a 8 mois 7 jours

MedMira reçoit un brevet canadien pour un système de diagnostic innovant

Innovation En Matière De Soins De Santé MedMira Brevet Canadien Système De Diagnostic Technologie RVF
COMMUNIQUÉ DE PRESSE

publié le 13/03/2024 à 21:30, il y a 8 mois 7 jours

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
MedMira Inc. announces the receipt of a Canadian patent for a new quantitative test system using Rapid Vertical Flow Technology, enhancing its diagnostic tests. The system offers qualitative and quantitative results in minutes, revolutionizing disease screening and monitoring

MedMira Inc. Canadian Patent Quantitative Test System Rapid Vertical Flow Technology Diagnostic Tests
COMMUNIQUÉ DE PRESSE

publié le 01/02/2024 à 14:10, il y a 9 mois 19 jours

CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products
MedMira Inc. provides an update on its submission to Health Canada, extending its intended use to address the increasing need in maternity screening. The company's syphilis component demonstrates promising results, with plans to submit a comprehensive dataset for additional claims approval by February 2024

MedMira Inc. Maternity Screening Health Canada Syphilis Comprehensive Dataset
COMMUNIQUÉ DE PRESSE

publié le 01/02/2024 à 13:35, il y a 9 mois 20 jours

Corporate Update on Clinical Evaluation of MedMira’s Products
MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening

MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance

Les Echos

Publié le 21/11/2024 à 06:58, il y a 6 heures 49 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 49 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 49 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 40 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 27 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 13:30, il y a 17 minutes

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:30, il y a 17 minutes

Datametrex Secures Additional P.O. Approx $250K for IT Services
Publié le 21/11/2024 à 13:00, il y a 47 minutes

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 47 minutes

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 47 minutes

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 13:15, il y a 32 minutes

NOTICE OF ANNUAL GENERAL MEETING
Publié le 21/11/2024 à 12:35, il y a 1 heure 12 minutes

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 32 minutes

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Publié le 21/11/2024 à 12:06, il y a 1 heure 40 minutes

IVU AG publishes Quarterly Report Q3-2024
Publié le 21/11/2024 à 12:00, il y a 1 heure 47 minutes

Holding(s) in Company